• Learning Objective 1:  To describe the purpose and goals of the Precision Medicine in Diabetes Initiative
  • Learning Objective 2:  To highlight monogenic diabetes as an exemplar of diabetes precision medicine
  • Learning Objective 3:  To describe on-going efforts to bring precision medicine to polygenic forms of diabetes
Session date: 
09/08/2022 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Rochelle Naylor, MD